Studies showed that in myeloma, CSGALNACT1 was under-expressed in MM cells compared to normal bone marrow plasma cells, which suggest that the overexpression of CSGALNACT1 is associated with a good prognosis (Bret et al., 2009). This evidence concerns the gene CSGALNACT1 and plasma cell myeloma.